NCT06606119

Brief Summary

Traumatic injury followed by critical illness provokes pathophysiologic changes in the bone marrow and the gut that contribute to persistent anemia and changes in the microbiome which significantly impact long-term recovery. This project will define the interactions between the stress, chronic inflammation, bone marrow dysfunction, and an altered microbiome which will provide a strong foundation for future clinical interventions to help improve outcomes following severe trauma.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
275

participants targeted

Target at P75+ for all trials

Timeline
29mo left

Started Jan 2025

Typical duration for all trials

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress35%
Jan 2025Oct 2028

First Submitted

Initial submission to the registry

September 18, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 20, 2024

Completed
4 months until next milestone

Study Start

First participant enrolled

January 24, 2025

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2028

Last Updated

February 6, 2026

Status Verified

February 1, 2026

Enrollment Period

2.7 years

First QC Date

September 18, 2024

Last Update Submit

February 4, 2026

Conditions

Keywords

Hematopoietic Stem Progenitor CellsBone Marrow FailureAnemiaGut MicrobiomeInflammationDysregulated Stress Response

Outcome Measures

Primary Outcomes (3)

  • Link the changes in HSPC and erythroid progenitor cell fate and function with sympathetic stress-induced changes establishing brain-bone marrow communication following trauma.

    The impact of the severity and duration of catecholamine secretion on the cellular biology of HSPCs and erythroid progenitor cells requires further detailed evaluation. At each stage of proliferation and differentiation, there is a complex interaction of cytokines, transcription factors, post-translational modification of histones, and miRs. Single-cell RNA-seq technologies using a novel second generation multi-omics technology, CITE-seq, will be used for identification of isolated HSPCs and erythroid progenitor cells. Such single cell sequencing technology is ideal for cell populations with a great deal of heterogeneity and is well-suited for bone marrow analysis. Isolated cells can then be characterized by their transcriptomic and epigenetic changes. We will also evaluate EVM cargo (specific proteins/RNA/miR) from both plasma and bone marrow to determine links to chronic stress exposure.

    3 years

  • Determine the connection between changes in the microbiome with sympathetic stress-induced changes establishing gut-brain communication following trauma.

    Focusing on the effects of autonomic nervous system on gut function and immune responses, in the setting of sympathetic activation, a serial evaluation of the gut microbiota and their metabolic products (ex. SCFAs: butyrate, propionate, and acetate) will be performed in trauma patients. Correlation of microbial diversity and alterations of the taxonomic composition will be correlated with plasma markers of inflammation and clinical outcomes. Longitudinal study of the trauma pathobiome will elucidate clinical course patterns (recovery and CCI) with microbial composition. The unique biology of the microbiome in different sexes and age groups will require additional subgroup analysis.

    3 years

  • Link changes in the microbiome with altered HSPC and erythroid progenitor cells fate establishing gut-bone marrow communication following trauma

    We will examine how stress-induced changes following trauma create a pathobiome that modulates HPSC differentiation and maintains altered erythroid progenitor function. The microbiota play a role in both lineage differentiation and also control systemic iron homeostasis by inhibiting intestinal absorption and increasing cellular iron storage. Bone marrow macrophages have a key role in late-stage erythropoiesis by supplying local iron to erythroblasts for hemoglobin production. Isolation of bone marrow macrophages and erythroblasts involved in EBIs and determination of local iron content will define microbiome-induced changes in terminal erythropoiesis.

    3 years

Study Arms (2)

Major Trauma Injury

Severe blunt trauma patients diagnosed with shock with a long bone or pelvic fracture requiring open reduction internal fixation or intramedullary fixation.

Other: Data and tissue collection

Elective Hip Replacement

Patients undergoing elective hip replacement surgery

Other: Data and tissue collection

Interventions

Collection of bone marrow, blood, feces, medical record data, and patient response surveys.

Elective Hip ReplacementMajor Trauma Injury

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Acute Care Trauma ICU - Severe Blunt Trauma Orthopedic Injury Shock Orthopedic Clinic - Elective Hip Replacement

You may qualify if:

  • All adults (age ≥18).
  • Blunt trauma with an injury severity score \> 15 and a long bone or pelvic fracture requiring open reduction internal fixation or intramedullary fixation
  • Blunt trauma patients with shock, defined by either a systolic BP (SBP) \<90 mm Hg or base deficit (BD) ≥5 meq or lactate ≥ 2 mmol/L or active red blood cell or whole blood transfusion within 6h or arrival

You may not qualify if:

  • Patients not expected to survive greater than 48 hours
  • Prisoners
  • Pregnancy
  • Previous bone marrow transplantation
  • Patients receiving chronic corticosteroids or immunosuppression therapies
  • Patients with End Stage Renal Disease
  • Patients with any pre-existing hematological disease
  • Surgery for repair of injury is greater than seven days after admission to the hospital for trauma
  • Burn injury greater than 20% TBSA
  • Elective Hip Cohort
  • All adults (age ≥55).
  • Patient undergoing elective hip repair for non-infectious reasons.
  • Ability to obtain Informed Consent prior to operation.
  • Patients not expected to survive greater than 48 hours
  • Prisoners
  • +5 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

UF Academic Research Building

Gainesville, Florida, 32610, United States

RECRUITING

UF Health at Shands Hospital

Gainesville, Florida, 32610, United States

RECRUITING

UF Laboratory of Inflammation Biology and Surgical Science and Shands Hospital at UF

Gainesville, Florida, 32610, United States

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Bone Marrow, Blood, Feces

MeSH Terms

Conditions

Accidental InjuriesWounds and InjuriesCritical IllnessBone Marrow Failure DisordersAnemiaInflammation

Interventions

Tissue Banks

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBone Marrow DiseasesHematologic DiseasesHemic and Lymphatic Diseases

Intervention Hierarchy (Ancestors)

Biological Specimen BanksHealth FacilitiesHealth Care Facilities Workforce and Services

Study Officials

  • Alicia Mohr, MD

    University of Florida

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 18, 2024

First Posted

September 20, 2024

Study Start

January 24, 2025

Primary Completion (Estimated)

October 1, 2027

Study Completion (Estimated)

October 1, 2028

Last Updated

February 6, 2026

Record last verified: 2026-02

Locations